1. Home
  2. TECX vs EMX Comparison

TECX vs EMX Comparison

Compare TECX & EMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECX
  • EMX
  • Stock Information
  • Founded
  • TECX 2019
  • EMX N/A
  • Country
  • TECX United States
  • EMX Canada
  • Employees
  • TECX N/A
  • EMX N/A
  • Industry
  • TECX
  • EMX
  • Sector
  • TECX
  • EMX
  • Exchange
  • TECX Nasdaq
  • EMX Nasdaq
  • Market Cap
  • TECX 387.1M
  • EMX 338.0M
  • IPO Year
  • TECX 2018
  • EMX N/A
  • Fundamental
  • Price
  • TECX $16.80
  • EMX $4.08
  • Analyst Decision
  • TECX Buy
  • EMX Strong Buy
  • Analyst Count
  • TECX 6
  • EMX 2
  • Target Price
  • TECX $79.17
  • EMX $5.38
  • AVG Volume (30 Days)
  • TECX 443.3K
  • EMX 708.4K
  • Earning Date
  • TECX 11-06-2025
  • EMX 11-06-2025
  • Dividend Yield
  • TECX N/A
  • EMX N/A
  • EPS Growth
  • TECX N/A
  • EMX N/A
  • EPS
  • TECX N/A
  • EMX 0.04
  • Revenue
  • TECX N/A
  • EMX $29,864,000.00
  • Revenue This Year
  • TECX N/A
  • EMX $11.08
  • Revenue Next Year
  • TECX N/A
  • EMX $3.72
  • P/E Ratio
  • TECX N/A
  • EMX $91.28
  • Revenue Growth
  • TECX N/A
  • EMX N/A
  • 52 Week Low
  • TECX $13.70
  • EMX $1.59
  • 52 Week High
  • TECX $61.07
  • EMX $4.12
  • Technical
  • Relative Strength Index (RSI)
  • TECX 33.64
  • EMX 79.62
  • Support Level
  • TECX $15.34
  • EMX $3.76
  • Resistance Level
  • TECX $18.61
  • EMX $3.95
  • Average True Range (ATR)
  • TECX 1.71
  • EMX 0.15
  • MACD
  • TECX -1.06
  • EMX 0.06
  • Stochastic Oscillator
  • TECX 12.18
  • EMX 96.31

About TECX Tectonic Therapeutic Inc. Common Stock

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About EMX EMX Royalty Corporation (Canada)

EMX Royalty Corp and its subsidiaries operate as a royalty and prospect generator engaged in exploring for and generating royalties from, metals and minerals properties. The company is a precious, and base metals royalty company. The Company augments royalty generation with royalty acquisitions and strategic investments. EMX's royalty and mineral property portfolio consists of properties in North America, Europe, Turkiye, Latin America, Morocco and Australia.

Share on Social Networks: